For further details and to apply for this post, see
http://gs.globalsuccessor.com/fe/tpl_astrazenecav2.asp?
newms=jj&id=24354&aid=1610
Statisticians provide expert strategic and statistical advice to the
development of AstraZeneca products, from the transfer from Discovery,
through regulatory submissions to commercialisation and life cycle
management. This is an exciting opportunity to support early phase
development and the interface with Discovery (Discovery Medicine)
transitioning Oncology and Inflammation projects to Clinical. This will
involve supporting the use of Magnetic Resonance Imaging (MRI) in early
clinical studies, assessment of biomarkers in a clinical setting, advising
on the use of histopathological data in clinical studies, and the
incorporation of genomics into clinical studies. The successful candidate
will be involved in developing strategies for decision-making in early
phase development.
The closing date for receipt of applications is Tuesday 7th June 2005
Interviews are scheduled to take place on Friday 17th June 2005
|